Zobrazeno 1 - 10
of 21
pro vyhledávání: '"CSC, cancer stem cells"'
Publikováno v:
Oral Oncology Reports, Vol 10, Iss , Pp 100474- (2024)
Externí odkaz:
https://doaj.org/article/c0acfd0538f44a0dbe82d174fce71b48
Autor:
Abiola A. Ayanlaja, Ye Xiong, Yue Gao, GuangQuan Ji, Chuanxi Tang, Zamzam Abdikani Abdullah, DianShuai Gao
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 10 (2017)
Neuronal migration is a critical process in the development of the nervous system. Defects in the migration of the neurons are associated with diseases like lissencephaly, subcortical band heterotopia (SBH), and pachygyria. Doublecortin (DCX) is an e
Externí odkaz:
https://doaj.org/article/e1ec189389dc469484d2ef59349256ca
Autor:
Hirofumi Yamamoto, Tsunekazu Mizushima, Masaki Mori, Naotsugu Haraguchi, Hideshi Ishii, Norikatsu Miyoshi
Publikováno v:
Regenerative Therapy, Vol 17, Iss, Pp 13-19 (2021)
Regenerative Therapy
Regenerative Therapy
Although common cancer therapies, such as chemotherapy and radiation therapy, have recently improved and yielded good results, evaluated as tumor shrinkage, disease recurrence is still a common event for most cancer patients. This is termed refractor
Autor:
Taro Yamashita, Shuichi Kaneko
Publikováno v:
Regenerative Therapy, Vol 17, Iss, Pp 34-37 (2021)
Regenerative Therapy
Regenerative Therapy
The cancer stem cell (CSC) hypothesis was proposed over 4 decades ago and states that tumor growth is maintained by a small subset of cancer cells analogous to normal tissue stem cells in terms of self-renewal and differentiation capacity. Advances i
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Autor:
Paolo Ceppi, Aarif Siddiqui
Publikováno v:
Molecular Metabolism, Vol 35, Iss, Pp-(2020)
Siddiqui, A & Ceppi, P 2020, ' A non-proliferative role of pyrimidine metabolism in cancer ', Molecular Metabolism, vol. 35, 100962 . https://doi.org/10.1016/j.molmet.2020.02.005
Molecular Metabolism
Siddiqui, A & Ceppi, P 2020, ' A non-proliferative role of pyrimidine metabolism in cancer ', Molecular Metabolism, vol. 35, 100962 . https://doi.org/10.1016/j.molmet.2020.02.005
Molecular Metabolism
Background: Nucleotide metabolism is a critical pathway that generates purine and pyrimidine molecules for DNA replication, RNA synthesis, and cellular bioenergetics. Increased nucleotide metabolism supports uncontrolled growth of tumors and is a hal
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Journal of Bone Oncology, Vol 25, Iss, Pp 100315-(2020)
Journal of Bone Oncology
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Journal of Bone Oncology, Vol 25, Iss, Pp 100315-(2020)
Journal of Bone Oncology
© 2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/BY-NC-ND/4.0/)
Hepatocyte growth factor (HGF)/c-Met pathway is implicated in embryogenesis and
Hepatocyte growth factor (HGF)/c-Met pathway is implicated in embryogenesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f9006cf780943817f32d88292f26bb
Publikováno v:
Neoplasia (New York, N.Y.)
Prostate cancer generally metastasizes to bone, and most patients have tumor cells in their bone marrow already at diagnosis. Tumor cells at the metastatic site may therefore progress in parallel with those in the primary tumor. Androgen deprivation
Autor:
Anja Smits, Anna Wenger, Helena Carén, Fredrik B. Thorén, Alexander Hallner, Katja Werlenius, Asgeir Store Jakola, Bertil Rydenhag, Magnus Tisell, Dan Farahmand
Publikováno v:
Neoplasia
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 1, Pp 25-31 (2018)
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 1, Pp 25-31 (2018)
Glioblastoma (GBM) is the most aggressive primary brain tumor with a median survival of less than 15 months, emphasizing the need for better treatments. Immunotherapy as a treatment for improving or aiding the patient’s own immune defense to target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed6d1c5f25eaba56d11b34bb2a70e8e
https://hdl.handle.net/11250/3045011
https://hdl.handle.net/11250/3045011